1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015-2019 Japan Cancer Diagnostics Industry: Market Segmentation Analysis--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs

Complete report $8,800.  DataPack (test volumes, sales forecasts, supplier shares) $5,700.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. 


“2015-2019 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years.  The report examines trends in the Japanese market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.  


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the Japanese cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.


Japanese Market Overview


- Five-year test volume and sales projections.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of laboratories performing cancer diagnostic testing.


- Cancer statistics, etiology and recent developments in Japan.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test.


- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:


     º  Hospitals

     º  Commercial/Private Laboratories



Instrumentation Review


- Analysis of major molecular diagnostic and immunodiagnostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies.


- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments of major suppliers

and start-up firms developing innovative cancer diagnostic

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca Biopharma

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomedical Diagnostics

   - bioMerieux

   - Bio-Rad

   - CellSearch

   - Cepheid

   - Correlogic Systems/Vermillion

   - Decode Genetics

   - Diadexus

   - Diagnocure

   - DiaSorin

   - Eiken Chemical

   - Elitech Group

   - Epigenomics

   - Enterix

   - Enzo Biochem

   - Exact Sciences

   - Fujirebio

   - Guided Therapeutics

   - Hologic/Gen-Probe

   - Kreatech/Leica

   - Kyowa Medex

   - Mackay Life Sciences

   - Myriad Genetics

   - OncoLab

   - Ortho-Clinical Diagnostics

   - Panacea Pharmaceuticals

   - Polartechnics

   - Polymedco

   - PreMD

   - Qiagen

   - Quest Diagnostics

   - Radient Pharmaceuticals

   - Roche

   - Scienion

   - Sequenom

   - Siemens Healthcare

   - Takara Bio

   - Targeted Diagnostics & Therapeutics

   - Thermo Fisher

   - Tosoh

   - Veridex

   - Wako Pure Chemicals

   - Wallac/PE

   - Zilla


Contains 590 pages and 95 tables

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2015-2019 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the Japanese market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Table Of Contents

2015-2019 Japan Cancer Diagnostics Industry: Market Segmentation Analysis--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs
Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry:
Oncogenes, Bichemical Markers, Lymphokines, GFs, CSFs, Hormones,
Immunohistochemical Stains--Hospitals, and Commercial Labs
Partial Table of Contents
(Contact Client Services to receive complete Table of Contents)

I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers

2. Oncogenes

3. Polypeptide Growth Factors

4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
Table of Contents
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies

D. Personal Testing
VIII. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
Table of Contents
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications





List of Tables

Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests




List of Tables
Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis




List of Tables
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: Japan, Total Cancer
Diagnostic Testing Volume and Sales Forecasts
By Market Segment
Japan, Estimated Cancer Death Rates
Japan, Laboratories Performing Cancer
Diagnostic Tests by Market Segment
Japan, Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Cancer Diagnostic Tests
By Annual Test Volume
Japan, Total Cancer Diagnostic Testing Volume
Forecasts by Market Segment
Japan, All Market Segments Major Cancer
Diagnostic Test Volume Forecasts by Test
Japan, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts by Test
Japan, Commercial/Private Laboratories Major
Cancer Diagnostic Test Volume Forecasts
Japan, Total Cancer Diagnostic Sales
Forecasts by Market Segment
Japan, All Market Segments Major Cancer
Diagnostic Sales Forecasts by Test
Japan, Hospital Laboratories Major Cancer
Diagnostic Sales Forecasts by Test




List of Tables
Japan, Commercial/Private Laboratories Major
Cancer Diagnostic Sales Forecasts by Test
Japan, ACTH Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecasts by Market
Segment





List of Tables

Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecasts by Market
Segment




List of Tables
Japan, Occult Blood Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, PSA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, S-100 Protein Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecasts by Market Segment




List of Tables
Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Total Cancer Diagnostics
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier




List of Tables
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Industry in the UK

  • October 2016
    10 pages
  • Diagnostics  

  • United Kingdom  

View report >

Diagnostics Industry in the UK

  • October 2016
    10 pages
  • Diagnostics  

  • United Kingdom  

View report >

Biopsy Industry in the US

  • October 2016
    7 pages
  • Biopsy  

    Magnetic Resona...  

    Cancer  

  • United States  

View report >

Related Market Segments :

Diagnostics

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.